Target intelligence / Profile preview

Doublesex- and mab-3-related transcription factor A2 (DMRTA2)

Target
DMRTA2
Molecular classification
Transcription factor
01

Overview

Doublesex- and mab-3-related transcription factor A2 (DMRTA2) is a transcription factor within the DMRT family, characterized by a DM DNA-binding domain that is conserved from Drosophila (doublesex) and Caenorhabditis elegans (mab-3), both involved in developmental regulation[1][2][3]. DMRTA2 plays a critical role in the developing central nervous system, particularly by regulating the balance between proliferation and differentiation of neural progenitor cells (NPCs) during cortical development: it maintains NPCs in the cell cycle and inhibits their premature differentiation into neurons through direct transcriptional control of genes like Hes1[1][2]. Loss of function can cause cortical developmental disorders such as microcephaly. There is also evidence for possible involvement in sexual development, although this role is less defined compared to its neurodevelopmental functions[3]. DMRTA2 is not known to be a current therapeutic target, there are no established interacting drugs, and it is not used as a biomarker in clinical settings.

Other names
DMRTA2DMRT5Doublesex- and mab-3-related transcription factor 5DMRT like family A2
02

Biological functions

Regulation of neural progenitor cell (NPC) cell cycleRegulation of neuronal differentiation during brain developmentTranscriptional regulation of target genes such as Hes1[1][2]Potential involvement in sexual development[3]
03

Disease associations

Microcephaly and microlissencephaly (via brain malformations caused by disrupted neurogenesis) [1]Potential roles in neurodevelopmental disorders[3]

Beyond the preview

Go deeper on Doublesex- and mab-3-related transcription factor A2 (DMRTA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Doublesex- and mab-3-related transcription factor A2 (DMRTA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call